Eric Stephen Hamberger1, Bonnie Halpern-Felsher2. 1. Division of Pediatric Pulmonology and Sleep Medicine, Department of Pediatrics, UCLA, Los Angeles. 2. Division of Adolescent Medicine, Department of Pediatrics, Stanford University, Palo Alto, California, USA.
Abstract
PURPOSE OF REVIEW: This review highlights epidemiologic changes in e-cigarette use in adolescents, discusses recent advances in aerosolized nicotine delivery, and provides and updated profile of research related to the lung-specific harm of e-cigarettes. RECENT FINDINGS: In the past decade, nicotine-containing e-cigarettes have emerged as the most popular tobacco and nicotine delivery modality among adolescents in the United States. The surge in popularity of these devices has coincided with an outbreak of vaping-related lung injury, bringing e-cigarette use to national attention, and creating a great deal of confusion regarding their potential for respiratory harm. Newer pod-based devices and formulations of e-liquids have resulted in products appeal to youth and deliver nicotine with increasing efficiency. E-liquid aerosols are associated with direct harm to respiratory epithelium and have been shown to alter pulmonary function, inflammation, mucociliary clearance, and lung histology. SUMMARY: Although the long-term harms of regular e-cigarette use are unknown, numerous studies including early longitudinal data suggest e-cigarette use is associated with incidence of respiratory disease, independent of concurrent traditional cigarette use. Improved understanding and recognition of harm will contribute to the basis of further studies examining the role of e-cigarettes on chronic respiratory disease and will inform future prevention education.
PURPOSE OF REVIEW: This review highlights epidemiologic changes in e-cigarette use in adolescents, discusses recent advances in aerosolized nicotine delivery, and provides and updated profile of research related to the lung-specific harm of e-cigarettes. RECENT FINDINGS: In the past decade, nicotine-containing e-cigarettes have emerged as the most popular tobacco and nicotine delivery modality among adolescents in the United States. The surge in popularity of these devices has coincided with an outbreak of vaping-related lung injury, bringing e-cigarette use to national attention, and creating a great deal of confusion regarding their potential for respiratory harm. Newer pod-based devices and formulations of e-liquids have resulted in products appeal to youth and deliver nicotine with increasing efficiency. E-liquid aerosols are associated with direct harm to respiratory epithelium and have been shown to alter pulmonary function, inflammation, mucociliary clearance, and lung histology. SUMMARY: Although the long-term harms of regular e-cigarette use are unknown, numerous studies including early longitudinal data suggest e-cigarette use is associated with incidence of respiratory disease, independent of concurrent traditional cigarette use. Improved understanding and recognition of harm will contribute to the basis of further studies examining the role of e-cigarettes on chronic respiratory disease and will inform future prevention education.
Authors: Robert Bals; Jeanette Boyd; Susanna Esposito; Robert Foronjy; Pieter S Hiemstra; Carlos A Jiménez-Ruiz; Paraskevi Katsaounou; Anne Lindberg; Carlos Metz; Wolfgang Schober; Avrum Spira; Francesco Blasi Journal: Eur Respir J Date: 2019-01-31 Impact factor: 16.671
Authors: Danielle R Davis; Lisa M Fucito; Grace Kong; Asti Jackson; Krysten W Bold; Stephen R Baldassarri; Suchitra Krishnan-Sarin; Stephanie S O'Malley Journal: Nicotine Tob Res Date: 2020-01-06 Impact factor: 4.244
Authors: M Flori Sassano; Eric S Davis; James E Keating; Bryan T Zorn; Tavleen K Kochar; Matthew C Wolfgang; Gary L Glish; Robert Tarran Journal: PLoS Biol Date: 2018-03-27 Impact factor: 8.029
Authors: Fernando J Martinez; Alvar Agusti; Bartolome R Celli; MeiLan K Han; James P Allinson; Surya P Bhatt; Peter Calverley; Sanjay H Chotirmall; Badrul Chowdhury; Patrick Darken; Carla A Da Silva; Gavin Donaldson; Paul Dorinsky; Mark Dransfield; Rosa Faner; David M Halpin; Paul Jones; Jerry A Krishnan; Nicholas Locantore; Fernando D Martinez; Hana Mullerova; David Price; Klaus F Rabe; Colin Reisner; Dave Singh; Jørgen Vestbo; Claus F Vogelmeier; Robert A Wise; Ruth Tal-Singer; Jadwiga A Wedzicha Journal: Am J Respir Crit Care Med Date: 2022-02-01 Impact factor: 21.405
Authors: Jacob A Rohde; Seth M Noar; Jennifer Mendel Sheldon; Marissa G Hall; Talia Kieu; Noel T Brewer Journal: Nicotine Tob Res Date: 2022-08-06 Impact factor: 5.825